Aktiesnakken — November 2009
-
som genmabaktionær føler man sig jo nærmest privilegeret med kun glidende 40% efter FDA...
-
jeg glemte vist lige linket... så giver det nok mere mening http://borsen.dk/investor/nyhed/170756/
-
det er ikke lovligt noget sted.... såvidt jeg ved......
-
men om det sker i praksis ved jeg ikke...... jeg tror dog nok at det primært har været et amerikansk problem.
-
rebella??
-
at man ikke kan få sine gen aktier?
-
det lyder da mærkeligt
-
yep læser det....det kan være shorting
-
så genmab er nok en særdeles likvid aktie
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind